Literature DB >> 35405658

Duration of West Nile Virus Immunoglobulin M Antibodies up to 81 Months Following West Nile Virus Disease Onset.

J Erin Staples1, Katherine B Gibney1,2, Amanda J Panella1, Harry E Prince3, Alison J Basile1, Janeen Laven1, James J Sejvar4, Marc Fischer1.   

Abstract

West Nile virus (WNV) IgM antibodies typically indicate a recent infection. However, WNV IgM antibodies can remain detectable for months to years following illness onset. We found that 23% (11/47) of samples tested with a WNV ELISA and 43% (20/47) of samples tested with WNV microsphere immunoassay (MIA) at 16-19 months following WNV illness onset were positive for IgM antibodies. The proportion of samples testing positive for WNV IgM by ELISA decreased over time, but 5% (2/44) of individuals remained positive at 60-63 months after their acute illness and 4% (2/50) were WNV IgM equivocal at 72-81 months. Testing by MIA showed the same general trend of decreased proportion positive over time though the rates of positivity were higher at most time points compared with the ELISA, including 6% (3/50) of participant's samples identified as IgM positive by MIA at 72-81 months post their acute illness. With the MIA, there also was a high proportion of samples with nonspecific results at each time point; average of 23% across all time points. Clinicians and public health officials should consider these findings along with clinical and epidemiologic data when interpreting WNV IgM antibody test results.

Entities:  

Year:  2022        PMID: 35405658      PMCID: PMC9209930          DOI: 10.4269/ajtmh.21-1234

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  24 in total

Review 1.  Persistence of arboviruses and antiviral antibodies in vertebrate hosts: its occurrence and impacts.

Authors:  G Kuno
Journal:  Rev Med Virol       Date:  2001 May-Jun       Impact factor: 6.989

2.  B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus.

Authors:  A J McAdam; E A Farkash; B E Gewurz; A H Sharpe
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68.

Authors:  Shinichiro Fuse; Joshua J Obar; Sarah Bellfy; Erica K Leung; Weijun Zhang; Edward J Usherwood
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.

Authors:  Harry E Prince; Leslie H Tobler; Mary Lapé-Nixon; Gregory A Foster; Susan L Stramer; Michael P Busch
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus.

Authors:  P N Levett; K Sonnenberg; F Sidaway; S Shead; M Niedrig; K Steinhagen; G B Horsman; M A Drebot
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

6.  West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003.

Authors:  Amy V Bode; James J Sejvar; W John Pape; Grant L Campbell; Anthony A Marfin
Journal:  Clin Infect Dis       Date:  2006-03-30       Impact factor: 9.079

7.  Epidemiology of neuroinvasive arboviral disease in the United States, 1999-2007.

Authors:  Carolyn A Reimann; Edward B Hayes; Carolyn DiGuiseppi; Richard Hoffman; Jennifer A Lehman; Nicole P Lindsey; Grant L Campbell; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2008-12       Impact factor: 2.345

Review 8.  West Nile virus: review of the literature.

Authors:  Lyle R Petersen; Aaron C Brault; Roger S Nasci
Journal:  JAMA       Date:  2013-07-17       Impact factor: 56.272

9.  Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination.

Authors:  Katherine B Gibney; Srilatha Edupuganti; Amanda J Panella; Olga I Kosoy; Mark J Delorey; Robert S Lanciotti; Mark J Mulligan; Marc Fischer; J Erin Staples
Journal:  Am J Trop Med Hyg       Date:  2012-10-29       Impact factor: 2.345

10.  Persistence of detectable immunoglobulin M antibodies up to 8 years after infection with West Nile virus.

Authors:  Kristy O Murray; Melissa N Garcia; Chris Yan; Rodion Gorchakov
Journal:  Am J Trop Med Hyg       Date:  2013-09-23       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.